Abstract
OBJECTIVE: To describe how primary care clinicians can detect an eating disorder and identify and manage the associated medical complications.
DESIGN: A review of literature from 1994 to 1999 identified by a MEDLINE search on epidemiology, diagnosis, and therapy of eating disorders, including anorexia nervosa and bulimia nervosa.
MEASUREMENTS AND MAIN RESULTS: Detection requires awareness of risk factors for, and symptoms and signs of, anorexia nervosa (e.g., participation in activities valuing thinness, family history of an eating disorder, amenorrhea, lanugo hair) and bulimia nervosa (e.g., unsuccessful attempts at weight loss, history of childhood sexual abuse, family history of depression, erosion of tooth enamel from vomiting, partoid gland swelling, and gastroesophageal reflux). Providers must also remain alert for disordered eating in female athletes (the female athlete triad) and disordered eating in diabetics. Treatment requires a multidisciplinary team including a primary care practitioner, nutritionist, and mental health professional. The role of the primary care practitioner is to help determine the need for hospitalization and to manage medical complications (e.g., arrhythmias, refeeding syndrome, osteoporosis, and electrolyte abnormalities such as hypokalemia).
CONCLUSION: Primary care providers have an important role in detecting and managing eating disorders.
Similar content being viewed by others
References
leGrange D, Telch CF, Tibbs J. Eating attitudes and behaviors in 1,435 South African Caucasian and non-Caucasian college students. Am J Psychiatry. 1998;155:250–4.
Field AE, Colditz GZ, Peterson KE. Racial/ethnic and gender differences in concern with weight and in bulimic behaviors among adolescents. Obes Res. 1997;5:447–54.
Robinson TN, Killen JD, Litt IF, et al. Ethnicity and body dissatisfaction: are Hispanic and Asian women at increased risk for eating disorders? J Adoles Health. 1996;19:384–93.
American Psychiatric Association. Practice Guidelines for Eating Disorders. Am J Psychiatry. 1993;150:2–28.
Halmi KA, Eckert E, Marchi P, Sampugnaro V, Apple R, Cohen J. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry. 1991;48:712–8.
Eckert ED, Halmi KA, Marchi P, Grove W, Crosby R. Ten year follow-up of anorexia nervosa: clinical course and outcome. Psychol Med. 1995;25:143–55.
Comerci GD, Graydanus DE. Eating disorders: anorexia nervosa and bulimia. In: Hoffman ED, Graydanus DE, eds. Adolescent Medicine. Stamford, Conn: Appleton and Lange; 1997.
Bulik CM, Wullivan PF, Rorty M. Childhood sexual abuse in women with bulimia. J Clin Psych. 1989;50:460–4.
Fairburn CG, Agras WS, Wilson GT. The research on the treatment of bulimia nervosa: practical and theoretical implications. In: Anderson GH, Kennedy SH, eds. The Biology of Feast and Famine: Relevance to Eating Disorders. New York, NY: Academic Press; 1995:317–40.
Steen SN. The competitive athlete. In: Rickert VI, ed. Adolescent Nutrition: Assessment and Management. New York, NY: Chapman and Hall; 1996:223–47.
Tofler IR, Stryer BK, Micheli LJ. Physical and emotional problems of elite female gymnasts. N Engl J Med. 1996;335:281–3.
Rodin G, Craven J, Littlefield C, Murray M, Daneman D. Eating disorders and intentional insulin undertreatment in adolescent females with diabetes. Psychosomatics. 1991;32:171–6.
Steel JM, Young RJ, Lloyd GG, Clarke BF. Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications. BMJ. 1987;294:859–62.
Johnson GL, Humphries LL, Shirley PB, et al. Mitral valve prolapse in patients with anorexia nervosa and bulimia. Arch Intern Med. 1986;146:1525–9.
Meyers DG, Starke H, Pearson P, Wilken MK. Mitral valve prolapse in anorexia nervosa. Ann Intern Med. 1986;105:384–6.
Freund KM, Graham SM, Lesky LG, Moskowitz MA. Detection of bulimia in a primary care setting. J Gen Intern Med. 1993;8:243–8.
Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999;319:1467–8.
Sigman G. How has the care of eating disorder patients been altered and upset by payment and insurance issues? Let me count the ways. J Adolesc Health. 1996;19:317.
Katz RL, Keen CL, Hurley LS, Kellams-Harrison KM, Glader LJ. Zinc deficiency in anorexia nervosa. J Adolesc Health Care. 1987;8:400–6.
Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eating Disord. 1994;15:251–5.
Szmuckler GI, Young GP, Miller G, Lichenstein M, Binns DS. A controlled trial of cisapride in anorexia nervosa. Int J Eating Disorders. 1995;17:347–57.
Isner JM, Roberts WC, Heymsfield SB, Yager J. Anorexia nervosa and sudden death. Ann Intern Med. 1985;102:49–52.
Bhanji S, Mattingly D. Anorexia nervosa: some observations on “dieters” and “vomiters.” Brit J Psych. 1981;139:238–41.
Rampling D. Acute pancreatitis in anorexia nervosa. Med J Aust. 1980;74:126–32.
Saleeh JW, Lebwohol P. Metoclopromide-induced gastric emptying in patients with anorexia nervosa. Amer J Gastroenterol. 1980;74:127–32.
Stewart DE, Robinson E, Goldbloom DS, Wright C. Infertility and eating disorders. Am J Obstet Gynecol. 1990;163:1196–9.
Sobanski E, Hiltmann WD, Blanz B, Klein M, Schmidt MH. Pelvic ultrasound scanning of the ovaries in adolescent anorectic patients at low weight and after weight recovery. Eur Child Adolesc Psychiatry. 1997;6:207–11.
Lai KY, de Bruyn R, Lask B, Bryant-Waugh R, Hankins M. Use of pelvic ultrasound to monitor ovarian and uterine maturity in childhood onset anorexia nervosa. Arch Dis Child. 1994;71:228–31.
Treasure JL, Wheeler M, King EA, Gordon PA, Russell GF. Weight gain and reproductive function: ultrasonographic and endocrine features in anorexia nervosa. Clin Endocrinol. 1988;29: 607–16.
Croyan MS, Ibbertson HK. Low serum T3 and hypothyroidism in anorexia nervosa. J Clin Endocrinol Metab. 1977;44:167–72.
Gold PW, Gwirtsman H, Avgerinow PC, et al. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: pathophysiologic mechanism in underweight and weight-corrected patients. N Engl J Med. 1986;314:1335–42.
Nestel PJ. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. J Clin Endocrinol Metab. 1979;38:325–9.
Gold P, Kaye W, Robertson GI, Ebert M. Abnormalities in plasma and CSF arginine vasopressin in patients with anorexia nervosa. N Engl J Med. 1983;308:1112–23.
Silverman JA. Anorexia nervosa: clinical observations in a successful treatment plan. J Pediatrics. 1974;84:68–73.
Reiger W, Brady JP, Weisberg E. Hematologic changes in anorexia nervosa. Am J Psychiatry. 1978;135:984–5.
Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med. 1984;311:1601–6.
Rencken ML, Chesnut CH, Drinkwater BL. Bone density at multiple skeletal sites in amenorrheic athletes. JAMA. 1996;276:238–40.
Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa: a longitudinal study of cortical bone mass. JAMA. 1991;265:1133–8.
Drinkwater BL, Nilson K, Chestnut CH, Bremner WJ, Shainholtz S, Southworth MB. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. 1984;311:277–81.
Cumming DC. Exercise-associated amenorrhea, low bone density and estrogen replacement therapy. Arch Intern Med. 1996;156:2193–5.
Recker R, Davies KM, Hinders SM, Heaney RP, Stegman R, Kimmel DB. Bone gain in young adult women. JAMA. 1992;268:2403–8.
Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995;80:898–904.
Hergenroeder AC, O’Brian Smith E, Shypailo R, Jones LA, Klish WJ, Ellis K. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone or placebo over 12 months. Am J Obstet Gynecol. 1997;176:1017–25.
Black DM, Cummings SR, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535–41.
Hosking D, Chilvers CED, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med. 1998;338:485–92.
McClung M, Clemmensen B, Daifotis A, et al. Alendronate prevents postmenopausal bone loss in women without osteoporosis. Ann Intern Med. 1998;128:253–61.
Robin AL, Siegel PT, Koepke T, Moye AW, Tice S. Family therapy versus individual therapy for adolescent females with anorexia nervosa. J Dev Behav Pediatr. 1994;15:111–6.
Eisler I, Dare C, Russell GF, Szmukler G, LeGrange D, Dodge E. Family and individual therapy in anorexia nervosa. A 5-year follow-up. Arch Gen Psychiatry. 1997;54:1025–30.
Gowers S, Norton K, Halek C, Crisp AH. Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. Int J Eating Disord. 1994;15:165–77.
Treasure J, Todd G, Brolly M, Tiller J, Nehmed A, Denman F. A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav Res Ther. 1995;33:363–7.
Fairburn CG, Shafran R, Cooper Z. A cognitive behavioral theory of anorexia nervosa. Behav Res Ther. 1999;37:1–13.
Halmi KA, Eckert E, LaDu TJ, Cohen J. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry. 1986;43:177–81.
Gwirtsman HE, Guze BH, Yager J, Gainsley B. Fluoxitene treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry. 1990;51:378–82.
Kaye WH, Weltzin TE, Hsu LK, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry. 1991;52:464–71.
Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry. 1998;155:548–51.
Garfinkel PE, Garner DM. The Role of Drug Treatments for Eating Disorders. New York, NY: Brunner/Mazel; 1987.
Wells LA, Logan KM. Pharmacologic treatment of eating disorders: a review of selected literature and recommendations. Psychosomatic. 1987;28:470–9.
House RC, Grisius R. Periomolysis: unveiling the surrepitious vomiter. Oral Surg. 1981;6:152–5.
Clark DC. Oral complications of anorexia nervosa and/or bulimia: with a review of the literature. J Oral Med. 1985;40:134–8.
Dawsen J, Jones C. Vomiting induced hypokalemic alkalosis and parotid swelling. Practitioner. 1977;28:267–8.
Levin PA, Falko JM, Dixon K, Gallup EM, Saunders B. Benign parotid enlargement in bulimia. Ann Intern Med. 1980;93:827–9.
Walsh BT, Croft CB, Katz JL. Anorexia nervosa and salivary gland enlargement. Int J Psychiatry Med. 1981;11:255–61.
Larsen K, Skov Jensen B, Axelsen F. Perforation and rupture of the esophagus. Scand J Thorac Cardiovas Surg. 1983;17:311–6.
Saul SH, Dekker A, Watson CG. Acute gastric dilatation with infarction and perforation. Report of fatal outcome in patient with anorexia nervosa. Gut. 1981;22:978–83.
Mitchell JE, Pyle RL, Miner RA. Gastric dilatation as a complication of bulimia. Psychosomatics. 1982;23:96–7.
Breslow M, Yates A, Shisslak C. Spontaneous rupture of the stomach: a complication of bulimia. Int J Eating Disorders. 1986;5:137–42.
Mitchell JA, Boutacoff LI. Laxative abuse complicating bulimia: medical and treatment implications. Int J Eating Disorders. 1986;5:325–34.
Cummings JH. Laxative abuse. Gut. 1974;15:758–66.
Cooke WT. Laxative abuse. Clin Gastroenterol. 1977;6:659–73.
Al-Mufty NS, Bevan DH. A case of subcutaneous emphysema, pneumomediastinum and pneumoretroperitoneum associated with functional anorexia. Brit J Clin Pract. 1977;31:160–1.
Donley AJ, Kemple TJ. Spontaneous pneumomediastinum complicating anorexia nervosa. Br J Med. 1978;11:1604–5.
Brotman MC, Forbath N, Garfinkel PE, Humphrey JG. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa. Can Med Assoc J. 1981;125:453–4.
Adler AG, Walinsky P, Krall RA, et al. Death resulting from ipecac syrup poisoning. JAMA. 1983;243:1977–8.
Palmer EP, Guay AT. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med. 1986;313:1457–9.
Brotman AW, Rigotti N, Herzog DB. Medical complications of eating disorders: outpatient evaluation and management. Compr Psychiatry. 1985;26:258–72.
Mitchell JE, Pyle RI, Eckert ED, Hatsukami D, Lentz R. Electrolyte and other physiological abnormalities in patients with bulimia. Psychol Med. 1983;13:273–8.
Mitchell JE, Seim HC, Colon E, Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med. 1987;107:71–7.
Fairburn CG, Jones R, Peveler RC, Hope RA, O’Connor M. Psychotherapy and bulimia nervosa: the longer-term effects of interpersonal psychotherapy, behavior therapy and cognitive behavior therapy. Arch Gen Psychiatry. 1993;50:419–28.
Goldbloom DS, Olmsted M, Davis R, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short term outcome. Behav Res Ther. 1997;35:803–11.
Treasure J, Schmidt U, Troop N, Tiller J, Todd G, Turnbull S. Sequential treatment for bulimia nervosa incorporating a self-care manual. Br J Psychiatry. 1996;168:94–8.
Lewandowski LM, Gebing TA, Anthony JL, O’Brien WH. Meta-analysis of cognitive-behavioral treatment studies for bulimia. Clin Psychol Rev. 1997;17:703–18.
Thackwray DE, Smith MC, Bodfish JW, Meyers AW. A comparison of behavioral and cognitive-behavioral interventions for bulimia nervosa. J Consult Clin Psychology. 1993;61:639–45.
Garner DM, Rockert W, Davis R, Garner MV, Olmsted MP, Eagle M. Comparison of cognitive behavioral and supportive expressive therapy for bulimia nervosa. Am J Psychiatry. 1993;150:37–46.
Fairburn CG, Norman PA, Welch SL, O’Connor ME, Doll HA, Peveler RC. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry. 1995;52:304–12.
Walsh BT, Wilson GT, Loeb KL, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry. 1997;154:523–31.
Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry. 1990;47:149–57.
Agras WS, Rossiter EM, Arnow B, et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry. 1992;149:82–7.
Thiels C, Schmidt U, Treasure J, Garthe R, Troop N. Guided self-change for bulimia nervosa incorporating use of a self-care manual. Am J Psychiatry. 1998;155:947–53.
Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxitene in the treatment of bulimia nervosa: a multi-center placebocontrolled double blind trial. Am J Psychiatry. 1992;49:139–47.
Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH, Jr. Long term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry. 1995;166:660–6.
Fornari VM, Sandberg DE, Lachenmeyer J, Cohen D, Matthews M, Montero G. Seasonal variations in bulimia nervosa. Ann NY Acad Sci. 1989;575:509–11.
Lam RW, Solyom L, Tompkins A. Seasonal mood symptoms in bulimia nervosa and seasonal affective disorder. Compr Psychiatry. 1991;32:552–5.
Levitan RD, Kaplan AS, Rockert W. Chracterization of the “seasonal” bulimic patient. Int J Eating Dis. 1996;19:187–92.
Lam RW, Goldner EM, Soplyom L, Remick RA. A controlled study of light therapy for bulimia nervosa. Am J Psychiatry. 1994;151:744–9.
Blouin AG, Blouin JH, Iversen H, et al. Light therapy in bulimia nervosa: a double-blind, placebo controlled study. Psychiatry Res. 1996;60:1–9.
Braun D, Sunday S, Fornari V, Halmi K. Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo controlled study. Compr Psychiatry. 1999;40:442–8.
Rodin GM, Johnson LE, Garfinkel PE, Daneman D, Kenshole AB. Eating disorders in female adolescents with insulin-dependent diabetes mellitus. Int J Psychiatry Med. 1986;16:49–57.
Krowlewski AS, Warram JH, Cristlieb AR, Busick EJ, Kahn CR. Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40 year follow-up study. Diabetes Care. 1985;9:443–52.
Rydall AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med. 1997;336:1849–54.
American College of Sports Medicine. The female athlete triad: disordered eating, amenorrhea, osteoporosis: call to action. Sports Med Bulletin. 1992;27.
Carlat DJ, Camargo CA, Herzog DB. Eating disorders in males: a report on 135 patients. Am J Psychiatry. 1997;154:1127–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walsh, J.M.E., Wheat, M.E. & Freund, K. Detection, evaluation, and treatment of eating disorders. J GEN INTERN MED 15, 577–590 (2000). https://doi.org/10.1046/j.1525-1497.2000.02439.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2000.02439.x